Nottingham, United Kingdom

Mark Andrew Whitaker

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ferring B.v.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Andrew Whitaker. Retrieved from https://idiyas.com/inventor/mark-andrew-whitaker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Andrew Whitaker: Pharmaceutical Formulation Inventor

Introduction

Mark Andrew Whitaker is an inventor associated with Nottingham, Great Britain, and Ferring B.V. His work includes a patent concerning biodegradable polymer formulations for delivering gonadotropin-releasing hormone and related compounds.

Latest Patents

Whitaker is listed as an inventor on 1 patent: “Microparticles Comprising GnRH Made by PGSS.” The patent describes a pharmaceutical formulation with a solid matrix made from one or more biodegradable polymers. A pharmaceutically active substance, or an acceptable salt of that substance, is distributed homogeneously or substantially homogeneously within the matrix. Examples include gonadotropin-releasing hormone (GnRH), GnRH agonists, and GnRH antagonists.

Career Highlights

Whitaker’s listed patent reflects work in pharmaceutical formulation and drug-delivery technologies. The invention focuses on incorporating active substances into biodegradable polymer matrices.

Collaborations

Whitaker’s listed coworkers include Gregoire Charles Joseph Schwach and Lars Schiefelbein. The patent is associated with Ferring B.V.

Conclusion

Mark Andrew Whitaker’s patent work centers on biodegradable microparticle formulations designed to deliver GnRH and related pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…